IMAGO PHARMACEUTICALS, INC.
Biotech · Acquired
Small molecule JNK inhibitors for Alzheimer's disease, particularly IGP001
- Grants
- $282K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 18
- 3 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Evaluate Efficacy of a JNK Lead Compound, IGP001, in an In Vivo Alzheimer’s Disease Model | $282,424 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1157 | PALENA THERAPEUTICS, INC. | — | — |
| 1158 | ASTRAEA THERAPEUTICS, LLC | — | — |
| 1159 | NEUTHERAPEUTICS, LLC | — | — |
| 1160 | IMAGO PHARMACEUTICALS, INC. | — | — |
| 1161 | Trove Labs Inc | — | — |
| 1162 | NANOMEDIC INC | — | — |
| 1163 | AnkyrBio LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Inhibitors Of Jun N-terminal Kinaseapplication
- Therapeutic Antibodies For Treatment Of Neurodegenerationapplication
- Therapeutic Antibodies For Treatment Of Neurodegenerationgranted
- Inhibitors Of Jun N-terminal Kinaseapplication
- Inhibitors Of Jun N-terminal Kinaseapplication
- Treatment Of Fibrotic Disorders With Jun N-terminal Kinase Inhibitorsapplication
- Inhibitors Of Jun N-terminal Kinaseapplication
- Inhibitors Of Jun N-terminal Kinaseapplication
- Inhibitors Of LRRK2 Kinase Activityapplication
- Inhibitors Of Jun N-terminal Kinaseapplication
- Inhibitors Of Jun N-terminal Kinasegranted
- Spirocyclic Dihydro-thiazine And Dihydro-oxazine Bace Inhibitors, And Compositions And Uses Thereofgranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.